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Summary
 
Physiological levels of shear stress alter the genetic programm of cultured endothelial cells and are
associated with reduced cellular turnover rates and formation of atherosclerotic lesions in vivo.
To test the hypothesis that shear stress (15 dynes/cm
 
2
 
) interferes with programmed cell death,
apoptosis was induced in human umbilical venous cells (HUVEC) by tumor necrosis factor-
 
a
 
(TNF-
 
a
 
). Apoptosis was quantified by ELISA specific for histone-associated DNA-fragments
and confirmed by demonstrating the specific pattern of internucleosomal DNA-fragmentation.
TNF-
 
a
 
 (300 U/ml) mediated increase of DNA-fragmentation was completely abrogated by
shear stress (446 
 
6
 
 121% versus 57 
 
6
 
 11%, 
 
P
 
 
 
,
 
0.05). This anti-apoptotic activity of shear
stress decreased after pharmacological inhibition of endogenous nitric oxide (NO)-synthase by
N
 
G
 
-monomethyl-
 
l
 
-arginine and was completely reproduced by exogenous NO-donors.
The activation of interleukin-1
 
b
 
–converting enzyme (ICE)-like and cysteine protease protein
(CPP)-32-like cysteine proteases was required to mediate TNF-
 
a
 
–induced apoptosis of HUVEC.
Endothelial-derived nitric oxide (NO) as well as exogenous NO donors inhibited TNF-
 
a
 
–induced
cysteine protease activation. Inhibition of CPP-32 enzyme activity was due to specific S-nitrosyla-
tion of Cys 163, a functionally essential amino acid conserved among ICE/CPP-32–like proteases.
Thus, we propose that shear stress-mediated NO formation interferes with cell death signal
transduction and may contribute to endothelial cell integrity by inhibition of apoptosis.
 
O
 
ne of the most striking features of atherosclerosis is
the focal nature of the disease. Atherosclerotic lesions
preferentially develop in regions such as bends and bifurca-
tions, where blood flow is disturbed with flow separation
and, where shear stress is low and unsteady (1). The topo-
graphical association of regions with low shear stress with
increased cell turnover rates at lesion-prone sites in the ar-
terial tree (2) suggests an important link between local he-
modynamics and the associated wall shear stress and the
pathobiologic processes leading to endothelial cell injury and
atherosclerosis.
Cellular injury may result in either necrosis or apoptosis.
Apoptosis or programmed cell death is an essential mecha-
nism for the maintenance of homeostasis in multicellular or-
ganisms (3). Apoptosis refers to the morphological alterations
exhibited by “actively” dying cells that include cell shrink-
age, membrane blebbing, chromatin condensation, and DNA
fragmentation (3). Apoptotic cell death can result either
from developmentally controlled activation of endogenous
execution programs or from transduction of death signals
triggered by a wide variety of exogenous stimuli (4). One
major path in the cell suicide program requires the activa-
tion of cysteine proteases of the interleukin-1
 
b
 
–converting
enzyme (ICE)
 
1
 
-like and cysteine protease protein (CPP)-
32–like family, homologous to the product of the
 
 Cae-
norhabditis elegans
 
 cell death gene 
 
ced 3
 
 (5, 6).
We and others have previously shown, that the inflam-
matory cytokine tumor necrosis factor-
 
a
 
 (TNF-
 
a
 
) affects
endothelial cell viability and induces apoptosis in vitro in
bovine and porcine endothelial cells (7). Because vascular
wall shear stress alters the genetic growth program of cul-
tured endothelial cells (8), reduces endothelial cell turnover
rates (2, 9), and the development of atherosclerotic lesions
in vivo (1, 10, 11), we hypothesized that shear stress may
interfere with apoptosis of endothelial cells. In addition,
since shear stress is closely correlated with endothelial cell
nitric oxide (NO) production, we further investigated and
 
1
 
Abbreviations used in this paper:
 
 AFC, 7-amino-4-trifluoro-methylcoumarin;
AMC, 7-amino-4-coumarin; CCP, cysteine protease protein; DTNB,
5,5
 
9
 
dithiobis (2-nitrobenzoate); eNOS, endothelial NO-synthase; HUVEC,
human umbilical venous endothelial cells; ICE, interleukin-1
 
b
 
-converting
enzyme; LDH, lactate-dehydrogenase; LNMA, N
 
G
 
-monomethyl-
 
l
 
-arginine;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NO,
nitric oxide; SNP, sodium nitroprusside; SNAP, S-nitrosopenicillamine.
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identified a potential autocrine mechanism of NO for me-
diating the anti-apoptotic effects of shear stress.
 
Materials and Methods
 
Human umbilical venous endothelial cells (HUVEC), endo-
thelial basal medium, and supplements were purchased from Cell
Systems/Clonetics (Solingen, Germany) and FCS from Gibco (Ber-
lin, Germany). [
 
32
 
P]dCTP was delivered by Amersham (Braunsch-
weig, Germany). Klenow polymerase and cell death detection
ELISA were from Boehringer Mannheim (Mannheim, Ger-
many). ICE- and CPP32-substrates and inhibitors were delivered
by Bachem (Heidelberg, Germany).
 
Cell Culture and Shear Stress Exposure.
 
HUVEC were cultured
in endothelial basal medium supplemented with hydrocortisone
(1 
 
m
 
g/ml), bovine brain extract (3 
 
m
 
g/ml), gentamicin (50 
 
m
 
g/ml),
amphotericin B (50 
 
m
 
g/ml), epidermal growth factor (10 
 
m
 
g/ml),
and 10% fetal calf serum until the third passage. After detachment
with trypsin, cells were grown for at least 18 h. Confluent mono-
layers of HUVEC were grown onto 6-cm wells and exposed to
laminar fluid flow in a cone-and-plate apparatus as previously de-
scribed (12). A constant shear stress of 15 dynes/cm
 
2
 
 was used in
all experiments to simulate physiological shear stress (8, 12).
 
DNA Fragmentation.
 
Cells were scraped off the plates and
centrifugated at 700 
 
g
 
 for 10 min, washed with PBS and resus-
pended in incubation buffer. The histone-associated DNA-frag-
ments were linked to the anti-histone antibody from mouse and
the DNA-part of the nucleosome to the anti-DNA-peroxidase.
The amount of peroxidase retained in the immunocomplex was
determined photometrically with 2,2
 
9
 
-azino-di-(3-ethylbenzthia-
zoline sulfonate) as a substrate.
For the internucleosomal DNA-laddering, 1 
 
3
 
 10
 
6
 
 cells were
removed from culture flask, washed with PBS and incubated in
lysis buffer (5 mM Tris/HCl, pH 8, 20 mM EDTA and 0.5%
Triton X-100) for 15 min at 4
 
8
 
C. Then samples were incubated
with RNase A for 1 h at 37
 
8
 
C, followed by addition of a final
concentration of 0.5 mg/ml proteinase K and 1% SDS. The sam-
ples were then incubated overnight at 65
 
8
 
C. After isolation of
DNA by phenol-chloroform extraction the DNA was precipi-
tated with 70% isopropanol and 0.1 M NaCl. The resulting pellet
was resolved in TE buffer (10 mM Tris/HCl, pH 8, 1 mM
EDTA) and the DNA samples were incubated with 5 U of Kle-
now polymerase, 0.5 
 
m
 
Ci [
 
32
 
P]dCTP in the presence of 10 mM
Tris/HCl, pH 7.5, and 5 mM MgCl
 
2
 
 for 10 min at room temper-
ature according to Rösl et al. (13). The reaction was terminated
by addition of 10 mM EDTA and the unincorporated nucleotides
were removed with Sephadex G-50 spin columns. Labeled DNA
fragments were separated on a 1.0% agarose gel, transferred to ni-
trocellulose membranes, and exposed to x-ray film.
 
Determination of Cell Viability and LDH Release.
 
Cell viability
was assessed as described previously (14). HUVEC (1 
 
3 
 
10
 
5
 
 cells/ml)
were incubated in microtiter plates for 18 h with apoptotic stim-
uli. Then, cells were treated with 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT, 0.5 mg/ml) for 4 h at
37
 
8
 
C, medium was removed and cells were lysed with 2-isopro-
panol containing 0.04 M HCl. The metabolized MTT was deter-
mined photometrically (595 nm).
For measurement of lactate-dehydrogenase (LDH) levels, a kit
was used (Boehringer Mannheim, Germany). 1 
 
3 
 
10
 
5
 
 cells were
seeded into 12-well plates. The cell culture supernatant was incu-
bated with pyruvate and NADH and the LDH activity was deter-
mined photometrically according to the manufacturers protocols.
 
ICE and CPP32 Enzyme Activity.
 
For detection of ICE and
CPP32-activity, HUVEC (1 
 
3 
 
10
 
6
 
 cells) were lysed in buffer
(1% Triton X-100, 0.32 M sucrose, 5 mM EDTA, 1 mM PMSF,
1 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml leupeptin, 2 mM DTT, 10 mM Tris/
HCl, pH 8) for 15 min, 4
 
8
 
C, followed by centrifugation (20,000
 
 g
 
,
2 min). CPP-32–like activity was detected in resulting superna-
tants by measuring the proteolytic cleavage of the fluorogenic sub-
strate 7-amino-4-coumarin (AMC)-DEVD
 
 
 
(15) and AMC as stan-
dard in assay buffer (100 mM Hepes, 10% sucrose, 0.1% CHAPS,
pH
 
 
 
7.5, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml leupeptin, 2 mM
DTT) using an excitation wavelength of 380 nm and an emmission
wavelength of 460 nm. Similarly, ICE–like activity was measured
with 14 
 
m
 
M 7-amino-4-trifluoro-methylcoumarin (AFC)-conju-
gated YVAD-peptide as substrate and AFC as standard at an exci-
tation wavelength of 400 nm versus an emmission wavelength of
505 nm (16). Specificity for CPP-32/ICE–like enzymatic activity
was demonstrated by inhibition with 10 nM Ac-DEVD-CHO
and 10 
 
m
 
M Ac-YVAD-CHO, respectively (15–17). Protein con-
tent was analyzed using the Biorad assay (Biorad, München, Ger-
many). The specific activity of CPP32- and ICE-like protease ac-
tivity in homogenates of control cells was 3.6 
 
6
 
 0.6 pmol AMC 
 
3
 
mg protein
 
2
 
1
 
 
 
3
 
 min
 
2
 
1
 
 and 2.7 
 
6
 
 1.4 pmol AFC 
 
3
 
 mg protein
 
-1
 
 
 
3
 
min
 
-1
 
, respectively.
 
Cloning and Purification of ICE- and CPP-32 Subunits.
 
The hu-
man CPP-32 p17 and p12 subunits and the human ICE p10 and
p20 subunits were amplified by PCR with oligonucleotides that
were synthesized to contain BamH1 and SacI restriction sites and
were cloned into the respective sites of pQE30 (Qiagen, Hilden,
Germany) containing a 6
 
3
 
 histidine affinity tag. The cys 163-
mutated p17 was generated by amplification of pQE30-p17 by
PCR with the following primers: primer 1, 5
 
9
 
-GGAGGATC-
CCCTGGACAACAG-3
 
9
 
and primer 2, 5
 
9
 
-CTCAATGCCACAG-
TCCAGTTCTGTACCACGG
 
CC
 
GGCCTGAAT (exchanged
base pairs in bold) followed by an additional PCR with primer 1
and primer 3:5
 
9
 
-GTCGAGCTCAATGCCACAGTC containing
the SacI restriction site. Clones with verified sequence were ex-
pressed in 
 
Escherichia coli
 
. 
 
E. coli
 
 were lysed in buffer (8 M urea,
0.1 M Na-phosphate, 0.01 M Tris/HCl, pH 8) and the subunits
were purified by metal chelate affinity chromatography with
Ni
 
2
 
1
 
-nitrilo-triacetic acid (Ni-NTA) resins. After elution with
200 mM EDTA, the isolated subunits were renaturated by dialysis
overnight (18) and protein concentration was determined with
the Biorad assay with bovine serum albumine as standard. We ob-
tained 
 
z
 
6 mg purified protein/120 mg crude extract. Enzymatic
activity of the reconstituted CPP-32 (p17 and p12) and ICE sub-
units (p10 and p20) was monitored as outlined above. The spe-
cific activity of reconstituted ICE and CPP-32 in dialyzed crude
homogenates was 720 
 
6
 
 102 pmol AMC 
 
3
 
 mg protein
 
2
 
1
 
 
 
3 
 
min
 
2
 
1
 
and 318 
 
6
 
 78 pmol AFC 
 
3
 
 mg protein
 
2
 
1
 
 
 
3
 
 min
 
2
 
1
 
, respectively,
whereas the purified reconstituted proteins exhibited a specific ac-
tivity of 7,805 
 
6
 
 200 pmol AMC 
 
3
 
 mg protein
 
2
 
1
 
 
 
3
 
 min
 
2
 
1
 
 and
2,838 
 
6
 
 219 pmol AFC 
 
3
 
 mg protein
 
2
 
1
 
 
 
3
 
 min
 
2
 
1
 
, respectively.
 
S-Nitrosylation.
 
For demonstration of S-nitrosylation, bacteri-
ally expressed CPP-32 wild-type p17 subunit (p17 wt) and Cys
163-mutated p17 subunit (p17 mt) were purified as described
above and p17 subunits were renaturated by dialysis in 10 mM
Tris/HCl, pH 7.5, overnight (18). Then, 0.5 mg protein was in-
cubated in 30 mM Tris/HCl, pH 7.5, with NO released nonen-
zymatically by NaNO
 
2
 
 or sodium nitroprusside (SNP) (19, 20) for
the time indicated and again was dialysed overnight. S-nitrosyla-
tion was determined spectrophotometrically at 335 nm using an
extinction coefficient of 3,869 mol
 
2
 
1
 
 
 
3
 
 cm
 
2
 
1
 
 (19, 20), titration of
SH-groups was carried out with excess of 5,59dithiobis(2-nitroben-603 Dimmeler et al.
zoate) (DTNB) at 412 nm with an extinction coefficient of 13,600
mol21 3 cm21 (19).
Western Blot Analysis. For Western blotting proteins were
prepared and quantified as described above and protein samples
(60 mg) were resolved on 8% sodium dodecyl sulfate polyacryl-
amide-gels and blotted on membranes. Membranes were blocked
with 2% bovine serum albumin overnight and were incubated
with anti-endothelial NO-synthase antibody (1:2,500; Dianova,
Hamburg, Germany) for 1 h and anti-mouse horseradish peroxi-
dase conjugate as the second antibody. Next, the membranes
were stained with enhanced chemiluminescence. The autorad-
iographies were scanned and semiquantitatively quantified.
Results and Discussion
Shear Stress Prevents TNF-a-induced Apoptosis in Human
Endothelial Cells. TNF-a triggered apoptosis in HUVEC
in a time-dependent fashion with maximum effects after 18 h
exposure (Fig. 1 A). There was no increase in lactate de-
hydrogenase activity by TNF-a treatment excluding the in-
duction of cell necrosis (data not shown). Exposure of HU-
VEC to physiological levels (15 dynes/cm2) of laminar shear
stress dramatically reduced basal and TNF-a–triggered apop-
tosis. Shear stress results in an immediate increase in endo-
thelial NO production and further chronically enhances
NO synthesis by increasing endothelial NO-synthase ex-
pression (12, 21). In our experimental setting, NO synthe-
sis measured by cGMP levels increased more than twofold
5 min after the onset of shear stress. Furthermore, increased
protein levels of endothelial NO-synthase (eNOS) were
sustained for 18 h of shear stress exposure up to 150 6 10%
compared with controls. Although TNF-a slightly reduced
eNOS protein levels at baseline, shear stress increased eNOS
protein to a similar extent in the presence of TNF-a (132 6
4%). Inhibition of NO formation by NG-monomethyl-
l-arginine (LNMA) significantly inhibited the effect of shear
stress on the reduction of TNF-a–mediated cell death and
completely restored basal apoptosis (Fig. 1 A). Thus, physi-
ological concentrations of endogenous NO appear to be
capable of suppressing TNF-a–triggered apoptosis of HU-
VEC. To demonstrate the antiapoptotic potential of NO, we
investigated the effect of exogenous NO donors. Coincu-
bation with SNP or S-nitrosopenicillamine (SNAP) dose-
dependently decreased TNF-a–triggered apoptosis (Fig. 1 B).
NO donors did not affect apoptosis in the absence of TNF-a
(Fig. 1 B). Low concentrations up to 50 mM of NO-donors
were shown to be protective, whereas higher concentra-
tions (.300 mM) revealed the known proapoptotic effect
(22) (data not shown). TNF-a–induced apoptosis corre-
Figure 1. Inhibition of TNF-a–induced apoptosis by shear stress, nitric
oxide and ICE-like and CPP-32–like protease inhibitors in human endo-
thelial cells. (A) HUVEC were incubated with LNMA (1 mM) and/or
TNF-a (300 U/ml) for 18 h with or without additional shear stress (ss)
and DNA fragmentation was determined. Results are means 6 SE, with
*P ,0.05 versus TNF-a; **P ,0.05 versus TNF-a 1 shear stress. (B) Dose-
dependent inhibition of TNF-a–induced apoptosis by the NO donors
SNP and SNAP. HUVEC were incubated with SNP and SNAP with or
without TNF-a (300 U/ml) for 18 h and DNA fragmentation was mea-
sured. (C) Effect of protease inhibitors or NO donors on TNF-a induced
apoptosis after 18 h of incubation. Substances were added just before
TNF-a addition in the following concentrations: SNP and SNAP (10 mM);
ICE-like protease inhibitor Ac-YVAD-CHO and CPP-32–like inhibitor
Ac-DEVD-CHO (100 mM); 8-bromo-cGMP (1 mM). Results are means
6 SE, with *P ,0.05 versus TNF-a.604 Suppression of Apoptosis by Nitric Oxide
lated with a decrease of cell viability by 22 6 6%, which was
completely prevented by NO donors. The inhibition of
TNF-a–induced apoptosis by NO appeared to be indepen-
dent of elevated cGMP levels, since the cGMP analogue
8-bromo-cGMP did not affect DNA fragmentation (Fig. 1 C).
TNF-a-induced Apoptosis Depends on ICE/CPP32-like
Proteases Activity. To identify the antiapoptotic mecha-
nism of NO, we investigated the involvement of ICE/
CPP32–like proteases in TNF-a–mediated apoptosis in
HUVEC. Addition of the tetrapeptide inhibitors Ac-YVAD-
CHO and Ac-DEVD-CHO, which are specific inhibitors
of ICE-like (6, 17) and CPP-32–like (17, 23) proteases, re-
spectively, abrogated TNF-a–triggered apoptosis in HU-
VEC in a dose-dependent manner with maximum effects at
100  mM (Fig. 1 C). The inhibition of TNF-a–triggered
apoptosis by NO donors was equipotent to the effects of
the specific tetrapeptide protease inhibitors as assessed by den-
sitometric measurement of DNA fragmentation (Fig. 1 C).
Next, we measured ICE/CPP-32–like proteases activity
in HUVEC incubated for 18 h in the presence of TNF-a
(300 U/ml) and SNP or SNAP (10 mM). ICE- and CPP-
32–like protease activities were directly determined in the
homogenate. Exogenous NO completely suppressed the in-
crease in CPP-32–like protease activity induced by TNF-a
(Fig. 2 A). Similarly, endogenous NO, induced by shear
stress, also inhibited TNF-a stimulation of both proteases
(P 5 0.04), an effect completely reversed by addition of the
Figure 3. Direct inhibition of
ICE-like and CPP-32–like en-
zyme activity by NO. Inhibition
of ICE-like and CPP-32–like ac-
tivity in cell homogenates by
preincubation with various con-
centrations of SNP for 5 min.
Cell homogenates were obtained
from TNF-a–stimulated HUVEC
(300 U/ml for 18 h).
Figure 2.( A ) CPP-32–like activity in HUVEC treated with NO donors
(10 mM) or Ac-DEVD (100 mM) and TNF-a (300 U/ml) for 18 h. (B)
Northern blot analysis of CPP32. RNA from HUVEC was prepared after
6 h of incubation with TNF-a (300 U/ml), SNP and SNAP (10 mM) as in-
dicated. 10 mg of total RNA was resolved, blotted and sequentially hy-
bridized to full-length human cDNA of CPP-32 and GAPDH.605 Dimmeler et al.
NO-synthase inhibitor LNMA (99 6 3% of TNF-induced
CPP-32–like activity).
NO Inhibits ICE/CPP-32–like Protease Activity. Having
demonstrated that both endogenous as well as exogenous
NO inhibits the TNF-a–induced activation of ICE/CPP-
32–like proteases in intact cells, we next sought to examine
potential mechanisms, by which NO interferes with CPP-
32 activity. TNF-a increased the steady state expression of
CPP-32 mRNA in HUVEC after 6 h of incubation. How-
ever, neither the basal level of CPP-32 mRNA nor the
TNF-a–induced increase was affected in the presence of
NO donors (Fig. 2 B) suggesting a posttranscriptional mecha-
nism responsible for NO-mediated inhibition of CPP-32
activation. Therefore, we investigated the CPP-32 protein
as a potential direct target for NO-mediated interference.
In the next set of experiments, we treated homogenates of
TNF-a–stimulated endothelial cells with SNP and SNAP.
Both NO donors led to a dose-dependent decrease in
TNF-a induced CPP-32–like protease activity with an
IC50 value of about 50 mM for SNP (Fig. 3 A), when
added 3 min before starting the enzymatic reaction. This effect
was due to the NO-releasing capacity of the compounds
used, since controls with sodium cyanide (300 mM) did not
affect CPP-32–like enzyme activity (83 6 17% of control).
Similarly, ICE-like proteases activity was inhibited with
equal efficiency (Fig. 3 A).
Direct S-Nitrosylation of ICE/CPP32–like Proteases Down-
regulates Enzyme Activity. ICE- and CPP-32–like proteases
possess a highly conserved and functionally essential cys-
teine within their active center (5, 6, 23). Since S-nitrosy-
lation is a well-established mechanism, by which NO can
inhibit enzyme activity (19, 24, 25), we biochemically ana-
lyzed a potentially direct interaction of NO with CPP-32.
Upon activation, proteolytical cleavage of CPP-32 releases
two subunits, p12 and p17, which heterodimerize to form
the active protease (23). The p17 subunit contains the reac-
tive cysteine group at position 163 in its active center (23).
Therefore, both subunits were separately cloned, bacterially
expressed, and purified to homogeneity as demonstrated by
silver staining (Fig. 4 A). S-nitrosylation of the p17 subunit
was performed and detected according to Stamler (20). Ta-
ble 1 illustrates that NO released by NaNO2 or SNP time-
dependently S-nitrosylated one thiol group per molecule
p17. The S-nitrosylation correlated with the reduction of
one thiol-group per molecule p17 detectable by DTNB
(Table 1). These findings were further substantiated by
demonstrating that the isolated p17 subunit, but not the
p12 subunit NO-dependently incorporated [32P]NAD, a re-
action being mediated by S-nitrosylation (19, 26) (data not
shown). Similar results were obtained for the correspond-
ing p10/p20 subunits of ICE (data not shown).
In vitro reconstitution of both the p17 with the sepa-
rately expressed and purified p12 subunit of CPP32 as well as
the p20 and p10 subunit of ICE exhibited potent CPP32
and ICE enzyme activity, respectively. S-nitrosylation of
the p17-CPP32 or the p20-ICE subunit performed before
reconstitution led to a complete inhibition of enzyme ac-
tivity after SNP (500 mM)-induced S-nitrosylation for 60
min. Enzyme activity of both reconstituted heterodimers
was dose-dependently reduced by NO donors with equal
efficiencies (Fig. 4 B). Thus, S-nitrosylation of the p17 sub-
unit of CPP-32 or the p20 subunit of ICE is associated
with profound inhibition of enzyme activity.
The p17 subunit of CPP32 contains five cysteine groups.
To identify the NO acceptor amino acid, we mutated the
highly reactive Cys 163 to Ala 163 by PCR-cloning. No
Figure 4. Purification of p17
subunits and direct inhibition of
reconstituted CPP-32- and ICE-
subunits by NO. (A) Silver stain
of the crude homogenates be-
fore purification (60 mg; lane 3),
the unbound fraction of the Ni-
NTA columns (60 mg; lane 4)
and the purified CPP-32 p17
subunit (10 mg; lane 2) separated
by a 12% SDS–polyacrylamide
gel. (B) Inhibition of cloned, pu-
rified and reconstituted CPP-32
and ICE by incubation with SNP
or SNAP for 1 h.606 Suppression of Apoptosis by Nitric Oxide
reactive SH group was detectable, when titrating the SH
groups of the bacterially expressed p17 mutant (Table 1),
suggesting that Cys 163 is the main cysteine group which is
S-nitrosylated by NO. Interestingly, another mutant, Ser
120 to Gly 120, which abolished enzyme activity, but still
contains all five cysteine residues, was not S-nitrosylated
(data not shown), indicating that the ability to react with
NO depends on the formation of an active center.
NO, produced at low levels, has been previously shown
to inhibit apoptosis of human B cells, albeit the mecha-
nisms involved have not been elucidated (27, 28). In con-
trast, other studies have found that high levels of NO in-
duce apoptosis of macrophages (22). These effects of NO
activity as a double-edged sword can be well rationalized.
High concentrations of NO lead to direct DNA damage or
exhibit cytotoxic effects (29), whereas low levels of NO in-
hibit apoptosis via posttranslational modification of ICE/
CPP-32–like proteases by S-nitrosylation. The constitu-
tively expressed endothelial cell nitric oxide synthase pro-
duces low levels of NO (12, 21, 29) suggesting that endothe-
lial cell NO production may render endothelial cells resistant
to a major trigger of apoptosis. Although low concentrations
of exogenous NO were sufficient to prevent TNF-a–trig-
gered apoptosis, the pharmacological inhibition of shear
stress induced NO production did only partially reverse the
TNF-a effect (see Fig. 1 A). This result suggests that shear
stress utilizes additional NO-independent antiapoptotic mech-
anisms, which remain to be identified. Shear stress has pre-
viously been shown to modulate phosphorylation of tyro-
sine kinases (8) indicating activation of second messengers,
which might interfere with cell death signal transduction.
In addition, shear stress alters F-actin organization through
regulation of focal adhesion-associated proteins in endothe-
lial cells (8), which might play an additional role in mediat-
ing apoptosis (3, 4).
The function of NO to act as an intracellular control
mechanism to protect endothelial cells from being driven
into apoptosis under stimulation with TNF-a may have im-
portant pathophysiological implications. The endothelium
plays a pivotal role as a gate keeper regulating recruitment
of blood-borne cells during inflammation, atherosclerosis,
and immune surveillance. Since TNF-a is a major inflamma-
tory and/or immune cytokine, protection of TNF-a–induced
apoptosis of endothelial cells by NO might importantly
contribute to the integrity of the endothelial cell layer.
Moreover, since ICE-like and CPP-32–like proteases
play a crucial role not only in TNF-a and APO-1/FAS–
triggered apoptosis, but turn out to be of general impor-
tance in the apoptotic-signaling cascade (5, 17, 23), the po-
tential of low level NO to modulate ICE/CPP-32-like
proteases activity might have a general impact on the re-
sponse of cells to death signals.
Table 1. S-nitrosylation of Bacterially Expressed CPP-32 Wild-
type p17 Subunit (p17 wt) and Cys 163-mutated p17 (p17 mt)
p17 wt p17 mt
S-nitrosylation
Titration of
SH-groups
Titration of
SH-groups
S-NO/protein
SH-groups/
protein
SH-groups/
protein
mol/mol
Control 0 6 0 1.05 6 0.06 0.08 6 0.04
NaNO2 (30 min) 0.55 6 0.03 0.53 6 0.04 ND
NaNO2 (60 min) 1 6 0.04 0.06 6 0.03 ND
SNP (60 min) 0.99 6 0.01 0.1 6 0.09 ND
Data from three independent experiments are shown and expressed as
means 6 SE.
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